CHMP2B mutations have also been described in sporadic PMA patients, while mutations in MND-associated genes have been detected in familial ALS patients with predominantly LMN signs [15], [19], [28], [46], [47], [48], [49], [50]. Here, CHMP2B is linked to mild neurocognitive disorder.